Entelexo Biotherapeutics YC Application
Entelexo Biotherapeutics went through Y Combinator in the Winter 2021 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2021
- Industry
- HealthcareTherapeutics
- Team size
- 3
- Status
- Active
- Launched
- 2021
Founders
MILAD RIAZIFARFounder
Todd SchurrFounder
Cameron TaylorFounder
What Entelexo Biotherapeutics does
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
Entelexo Biotherapeutics's YC application, reconstructed
Y Combinator application
Entelexo Biotherapeutics, Winter 2021 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Entelexo Biotherapeutics
Creating drugs for incurable autoimmune diseases
We engineer exosome-based therapeutics to treat immune-mediated diseases like psoriasis. Our product uses biology-based drug candidates that modify immune system behavior where current treatments fail.
We live and work in Irvine, California, and we plan to keep the company based here after YC.
Irvine is where our research labs and core team are located. Staying here lets us maintain close ties to our scientific partners and a growing biotech ecosystem.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Entelexo Biotherapeutics YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Entelexo Biotherapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Entelexo Biotherapeutics would present itself to YC, not the text they submitted.
What YC batch was Entelexo Biotherapeutics in?
Entelexo Biotherapeutics was part of the Y Combinator Winter 2021 batch.
Who founded Entelexo Biotherapeutics?
Entelexo Biotherapeutics was founded by MILAD RIAZIFAR, Todd Schurr, Cameron Taylor.
What does Entelexo Biotherapeutics do?
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Entelexo Biotherapeutics's application, and every other YC batch, is in YC Insights.
More YC startups like Entelexo Biotherapeutics
